Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone

Binswanger, Ingrid A.; Glanz, Jason M.

doi:10.1007/s40264-018-0705-8

Cited by 10 publications

(5 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Overdose deaths among PWUD also reached historically unprecedented levels, exceeding 100,000 in a 12-month period by early 2021 (CDC, 2021 ). Recent incarceration is one of the greatest risk factors for overdose (Binswanger & Glanz, 2018 ; Binswanger, Nguyen, Morenoff, Xu, & Harding, 2020 ; Ranapurwala et al, 2018 ).…”

mentioning

confidence: 99%

“When people who use drugs can’t differentiate between medical care and cops, it’s a problem.” Compounding risks of law Enforcement Harassment & Punitive Healthcare Policies

Ostrach,

Hixon,

Bryce

2024

Health Justice

View full text Add to dashboard Cite

Background Community-based harm reduction programming is widely recognized as an effective strategy for reducing the increased risks for and spread of HIV, HCV, and for reducing the growing rate of overdose deaths among people who use drugs (PWUD). PWUD in the United States (US) are a highly justice-involved population, also at increased risk for law enforcement interaction, arrest, and incarceration. These risks compound and interact in the context of criminalization and law enforcement surveillance. Justice involvement increases risks for overdose and for riskier injecting behavior among PWUD, in turn increasing HCV and HIV risks. In Central and Southern Appalachia specifically, PWUD have identified fear of law enforcement harassment and arrest as a barrier to engaging in harm reduction behavior, and a deterrent to seeking help at the scene of an overdose. Moreover, stigmatizing and punitive treatment in healthcare settings can deter PWUD from seeking care, with life or death consequences. This evaluation research study assessing the successes and impacts of a grant-funded project to increase access to safer drug consumption supplies and overdose prevention education for PWUD, including justice-involved participants of a syringe access program (SAP), in public housing and beyond in a South-Central Appalachian setting used key informant and opportunistic sampling. Mixed-methods data were compiled and collected including secondary program data; primary interview and participant-observation data. Results The evaluation research identified that grant deliverables were largely achieved, despite challenges presented by the COVID-19 pandemic. In addition, SAP participants and staff reported larger themes surrounding grant-funded activities, in which they perceived that widespread local law enforcement harassment of PWUD increased participants’ risks for overdose death and infectious disease risks and that punitive local healthcare settings and policies acted as deterrents to care-seeking for many PWUD. Conclusions Overall, the evaluation research found that participants’ experiences with and perceptions of local law enforcement harassment combined with their understandings and experiences of local punitive healthcare settings and policies; together compounding and increasing overdose risks and negative health consequences for local justice-involved PWUD.

show abstract

mentioning

confidence: 99%

“When people who use drugs can’t differentiate between medical care and cops, it’s a problem.” Compounding risks of law Enforcement Harassment & Punitive Healthcare Policies

Ostrach,

Hixon,

Bryce

2024

Health Justice

View full text Add to dashboard Cite

show abstract

“…Individuals with more severe OUDs have reported that Vivitrol effectiveness decreases before the next injection, and individuals experience cravings for opioids (Knopf, 2019). This occurrence increases the likelihood of opioid overdose death, injury, or coma if an individual tries to challenge the opioid blockade (Binswanger & Glanz, 2018). However, Suboxone can be misused and abused.…”

Section: Suboxone and Vivitrol Comparisonmentioning

confidence: 99%

Reprint- Medication Assisted Treatment: Examining Enrollment and Demographic Factors of Treatment

J. Aragon

2024

IJCCR

View full text Add to dashboard Cite

Opioid Use Disorder (OUD) has been a long-standing epidemic concern related to the continuous growth of variations of the substance and its’ potency. Due to the versatility of the substance to be both an illicit drug and also a prescription medication, the interest in controlling and monitoring its’ use creates a greater public health concern. Treatment overtime has been revitalized to directly address the social, biological, and physiological difficulties of patients with OUDs. Medication Assisted Treatment (MAT) has been explored and has become one of the most widely used plans for treatment of substance use disorders (SUDs) related to pain management issues, dependency, withdrawal, and likelihood of maintaining sobriety. The use of MAT has been proven to be a positive and worthwhile addition to the treatment of OUDs. However, there are gaps in the administration and enrollment of individuals into the programs and facilities that offer MAT services. As this deficit is acknowledged, the current study was posed to examine the relationships among demographic factors relative to OUDs and MAT services. Data from a sample of 973 adults with a diagnosis of OUD relative to all opioid related substances, was analyzed in this study. Relationships among gender, race, employment, education, and types of treatment were explored. Types of treatment included Suboxone and Vivitrol. Overall, this study found that Suboxone treatment was administered more often than Vivitrol treatment. Also, outpatient service members used MAT services more often than inpatient members. Chi-square analyses and an Analysis of Variance were both utilized, indicating gender differences and educational differences. Likewise, specific race differences and employment attainment computed no significant conclusions. Contributions to the findings, limitations of the exploration, and future research directions are all discussed.

show abstract

“…Individuals with more severe OUDs have reported that Vivitrol effectiveness decreases before the next injection, and individuals experience cravings for opioids [52]. This occurrence increases the likelihood of opioid overdose death, injury, or coma if an individual tries to challenge the opioid blockade [53]. However, Suboxone can be misused and abused.…”

Section: Suboxone and Vivitrol Comparisonmentioning

confidence: 99%

Untitled

2023

CTCMS

View full text Add to dashboard Cite

show abstract

Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone

Cited by 10 publications

References 10 publications

“When people who use drugs can’t differentiate between medical care and cops, it’s a problem.” Compounding risks of law Enforcement Harassment & Punitive Healthcare Policies

“When people who use drugs can’t differentiate between medical care and cops, it’s a problem.” Compounding risks of law Enforcement Harassment & Punitive Healthcare Policies

Reprint- Medication Assisted Treatment: Examining Enrollment and Demographic Factors of Treatment

Untitled

Contact Info

Product

Resources

About